Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia-Reference-Cited by-同舟云学术

Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia

Published:2013-10-03 Issue:6 Volume:91 Page:546-551
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Barcellini Wilma¹,Zaja Francesco²,Zaninoni Anna¹,Imperiali Francesca Guia¹,Di Bona Eros³,Fattizzo Bruno¹,Consonni Dario⁴,Cortelezzi Agostino¹⁵,Zanella Alberto¹

Affiliation:

1. U.O. Ematologia e CTMO; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Milano Italy

2. Clinica Ematologica; DISM; Azienda Ospedaliera Universitaria; Udine Italy

3. Ematologia; Ospedale S. Bortolo; Vicenza Italy

4. U.O. Epidemiologia; Dipartimento della Medicina Preventiva; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Milano Italy

5. Università degli Studi di Milano; Milano Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12199/fullpdf

Reference27 articles.

1. Avoiding intuxication;Bussel;Blood,2012

2. International consensus report on the investigation and management of primary immune thrombocytopenia;Provan;Blood,2010

3. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006

4. European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis;Bertsias;Ann Rheum Dis,2012

5. Rituximab in the treatment of autoimmune haematological disorders;Garvey;Br J Haematol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic and lymphoid abnormalities in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease;Expert Review of Hematology;2024-06-13

3. Antibody based therapeutics for autoimmune hemolytic anemia;Expert Opinion on Biological Therapy;2023-11

4. The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia—A Review of Current Knowledge;Diagnostics;2023-09-09

5. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias;Leukemia;2023-05-18